Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MET097 in Overweight or Obesity
NCT07311850Phase 3Active, not recruiting
- Sponsor
- Pfizer
- Start
- Dec 2025
- Primary completion
- Sep 2027
- Modality
- Peptides
- Countries
- 10
01
Overview
A Phase 3 trial of PF-08653944 in obesity, Overweight, sponsored by Pfizer. Started Dec 2025; status: active, not recruiting.
02
Drugs
PF-08653944
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT07311850.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07311850.